Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2002 Apr;86(4):276–279. doi: 10.1136/adc.86.4.276

Short term effects of adrenaline in bronchiolitis: a randomised controlled trial

A Abul-Ainine 1, D Luyt 1
PMCID: PMC1719150  PMID: 11919104

Abstract

Background: Airway narrowing in acute bronchiolitis does not respond to inhaled bronchodilators but does to adrenaline when compared to bronchodilators. Influences of supportive care were not considered in previous treatment studies.

Methods: Short term effects of nebulised adrenaline and saline placebo were compared in infants with moderately severe acute bronchiolitis. Thirty eight infants were recruited, 19 in each treatment group. After stabilisation, infants received a single 3 ml dose of either levo-adrenaline (3 mg) or 0.9% saline placebo via Pari-BABY nebuliser driven with 6 l/min oxygen for three minutes. Changes in respiratory rate (RR), heart rate (HR), oxygen saturation (SpO2), Respiratory Distress Assessment Instrument (RDAI), and activity levels were assessed at 20 minutes intervals at times -20, 0, 20, 40, and 60 minutes around treatment. Respiratory virology and chest x ray were performed.

Results: Supportive therapy prior to study treatment resulted in significant reductions in RR (by 4.3 breaths/min) and HR (by 4.6 beats/min); there were no changes in SpO2 or RDAI. There were no further changes in any parameter in either treatment group at any assessment time after treatment.

Conclusion: No improvement was shown with inhaled adrenaline in acute bronchiolitis, when compared with supportive care or placebo. Improvements noted pretreatment question whether prior noted improvements were through supportive care or pharmacological interventions.

Full Text

The Full Text of this article is available as a PDF (126.5 KB).

Figure 1 .

Figure 1

Mean (95% CI) for respiratory rate, heart rate, oxygen saturation, and RDAI score for infants in each group at 0, 20, 40, and 60 minutes of assessment.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertrand P., Araníbar H., Castro E., Sánchez I. Efficacy of nebulized epinephrine versus salbutamol in hospitalized infants with bronchiolitis. Pediatr Pulmonol. 2001 Apr;31(4):284–288. doi: 10.1002/ppul.1040. [DOI] [PubMed] [Google Scholar]
  2. Court S. D. The definition of acute respiratory illnesses in children. Postgrad Med J. 1973 Nov;49(577):771–776. doi: 10.1136/pgmj.49.577.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Flores G., Horwitz R. I. Efficacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics. 1997 Aug;100(2 Pt 1):233–239. doi: 10.1542/peds.100.2.233. [DOI] [PubMed] [Google Scholar]
  4. Goodman B. T., Chambers T. L. Bronchodilators for bronchiolitis? Lancet. 1993 May 29;341(8857):1380–1380. doi: 10.1016/0140-6736(93)90949-h. [DOI] [PubMed] [Google Scholar]
  5. Kellner J. D., Ohlsson A., Gadomski A. M., Wang E. E. Efficacy of bronchodilator therapy in bronchiolitis. A meta-analysis. Arch Pediatr Adolesc Med. 1996 Nov;150(11):1166–1172. doi: 10.1001/archpedi.1996.02170360056009. [DOI] [PubMed] [Google Scholar]
  6. Kristjánsson S., Lødrup Carlsen K. C., Wennergren G., Strannegård I. L., Carlsen K. H. Nebulised racemic adrenaline in the treatment of acute bronchiolitis in infants and toddlers. Arch Dis Child. 1993 Dec;69(6):650–654. doi: 10.1136/adc.69.6.650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lenney W., Milner A. D. Alpha and beta adrenergic stimulants in bronchiolitis and wheezy bronchitis in children under 18 months of age. Arch Dis Child. 1978 Sep;53(9):707–709. doi: 10.1136/adc.53.9.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lowell D. I., Lister G., Von Koss H., McCarthy P. Wheezing in infants: the response to epinephrine. Pediatrics. 1987 Jun;79(6):939–945. [PubMed] [Google Scholar]
  9. Menon K., Sutcliffe T., Klassen T. P. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. J Pediatr. 1995 Jun;126(6):1004–1007. doi: 10.1016/s0022-3476(95)70234-2. [DOI] [PubMed] [Google Scholar]
  10. Price J. F. Acute and long-term effects of viral bronchiolitis in infancy. Lung. 1990;168 (Suppl):414–421. doi: 10.1007/BF02718159. [DOI] [PubMed] [Google Scholar]
  11. Reijonen T., Korppi M., Pitkäkangas S., Tenhola S., Remes K. The clinical efficacy of nebulized racemic epinephrine and albuterol in acute bronchiolitis. Arch Pediatr Adolesc Med. 1995 Jun;149(6):686–692. doi: 10.1001/archpedi.1995.02170190096017. [DOI] [PubMed] [Google Scholar]
  12. Sanchez I., De Koster J., Powell R. E., Wolstein R., Chernick V. Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics in infants with bronchiolitis. J Pediatr. 1993 Jan;122(1):145–151. doi: 10.1016/s0022-3476(05)83508-5. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES